CVS Chart

1 Month

	Date	Diff	Articles
	2025-05-02	-2.87 %	CVS Health (CVS) stock fell by 2.87% amid positive economic indicators lifting the broader stock market and concerns arising from its partnership with Novo Nordisk to distribute the Wegovy weight-loss drug at lower prices, which has created apprehension among Eli Lilly investors.
CVS Health (CVS) stock fell by 2.87% amid positive economic indicators lifting the broader stock market and concerns arising from its partnership with Novo Nordisk to distribute the Wegovy weight-loss drug at lower prices, which has created apprehension among Eli Lilly investors. The article discusses the significant decline of CVS Health (CVS) stock, which fell by 2.87%, while also promoting Bliss CBD Gummies as a health supplement that provides stress relief and improves well-being. CVS Health (CVS) stock may have decreased due to various factors such as market fluctuations, investor concerns about company performance, or broader economic conditions, but these specifics are not detailed in the article. CVS Health (CVS) stock fell 2.87% due to market concerns over a deal between CVS and Novo Nordisk that excludes Eli Lilly's weight-loss drug from its formulary, which could lead to increased competition and reduced profit margins in the GLP-1 medication market.
	2025-05-01	+4.11 %	CVS Health's stock rose by 4.11% due to its announcement that it would include rival weight-loss drugs Wegovy and Saxenda on its preferred formulary while excluding Eli Lilly's Zepbound, potentially increasing the accessibility of these medications and enhancing CVS's market competitiveness.
CVS Health's stock rose by 4.11% due to its announcement that it would include rival weight-loss drugs Wegovy and Saxenda on its preferred formulary while excluding Eli Lilly's Zepbound, potentially increasing the accessibility of these medications and enhancing CVS's market competitiveness. CVS Health's stock rose 4.11% after the company reported strong first-quarter results that exceeded expectations and raised its full-year adjusted earnings per share outlook, despite a lowered overall EPS forecast due to one-time factors. CVS Health (CVS) shares surged 7% following the release of its strong first-quarter financial results, which exceeded analyst expectations with a 7% year-over-year revenue increase to $94.59 billion and a more than 70% rise in adjusted EPS to $2.25, despite a cautious outlook for the year due to potential macroeconomic challenges. CVS Health stock increased by 4.11% amid a broader market rally driven by strong earnings reports from major companies like Microsoft and Meta Platforms, which boosted investor sentiment and confidence in the market. CVS Health's stock rose 4.11% following the company's announcement of a higher-than-expected 2025 earnings forecast, driven by improved Medicare benefits and better star ratings for its Medicare Advantage plans, leading to a 60% increase in profit for the first quarter.
	2025-04-30	+2.58 %	CVS Health (CVS) stock rose 2.58% ahead of its upcoming earnings report, driven by positive analyst expectations for a significant year-over-year earnings increase and strong recent stock performance, despite bearish sentiment in options trading that may lead to a contrarian rally if earnings exceed projections.
CVS Health (CVS) stock rose 2.58% ahead of its upcoming earnings report, driven by positive analyst expectations for a significant year-over-year earnings increase and strong recent stock performance, despite bearish sentiment in options trading that may lead to a contrarian rally if earnings exceed projections.
	2025-04-29	+0.15 %	CVS Health (CVS) stock rose by 0.15% as it prepares to release its earnings report, with analysts projecting higher earnings per share and revenue growth driven by increased prescription volumes and inflation in drug prices.
CVS Health (CVS) stock rose by 0.15% as it prepares to release its earnings report, with analysts projecting higher earnings per share and revenue growth driven by increased prescription volumes and inflation in drug prices. CVS Health (NYSE:CVS) stock rose by 0.15% as it is viewed favorably amid a positive earnings season and favorable management changes, despite challenges faced by other health insurers. The stock's increase can be attributed to strong performance metrics revealed by new management and a generally favorable market environment free from significant political disruptions, allowing investors to focus more on corporate outcomes. CVS Health (CVS) stock rose 0.15% after receiving a "Moderate Buy" rating from analysts, with several firms increasing their price targets and positive earnings results, indicating strong investor confidence. CVS Health (CVS) stock experienced a slight increase of 0.15%, attributed to positive earnings report performance that beat consensus estimates, despite a lowered earnings forecast from Leerink Partners.
	2025-04-24	+0.53 %	CVS Health Corporation (NYSE:CVS) stock rose by 0.53% due to an improvement in expectations following the announcement of favorable Medicare rates for 2026, which supported a recovery in its earnings power and highlighted the company's attractive long-term assets and strategic position in the healthcare sector.
CVS Health Corporation (NYSE:CVS) stock rose by 0.53% due to an improvement in expectations following the announcement of favorable Medicare rates for 2026, which supported a recovery in its earnings power and highlighted the company's attractive long-term assets and strategic position in the healthcare sector.
	2025-04-23	+0.18 %	CVS Health (CVS) stock rose by 0.18% due to positive updates from Morgan Stanley and Baird regarding its price targets, key management changes within the company, and optimistic financial forecasts for 2025 that have improved investor sentiment.
CVS Health (CVS) stock rose by 0.18% due to positive updates from Morgan Stanley and Baird regarding its price targets, key management changes within the company, and optimistic financial forecasts for 2025 that have improved investor sentiment. CVS Health (CVS) stock rose by 0.18% last night, possibly due to positive market sentiment or developments related to the company's overall performance in the healthcare and retail sectors. CVS Health (CVS) stock increased by 0.18% following the announcement of a new online map locator for misoprostol availability in New Orleans, reflecting the company's involvement in reproductive health amidst evolving state legislation, which may indicate a response to potential demand for the medication.
	2025-04-22	+0.43 %	The article discusses CVS Health Corporation's position in the telehealth sector, noting that its stock increased by 0.43% recently; the rise in CVS stock is attributed to its significant involvement and competitiveness within the telehealth market, highlighting its potential for growth in this area.
The article discusses CVS Health Corporation's position in the telehealth sector, noting that its stock increased by 0.43% recently; the rise in CVS stock is attributed to its significant involvement and competitiveness within the telehealth market, highlighting its potential for growth in this area.
	2025-04-21	-3.15 %	CVS Health (CVS) stock fell 3.15% recently amid a broader market downturn driven by investor concerns over President Trump's economic policies and his criticisms of Federal Reserve chair Jerome Powell, contributing to overall market volatility.
CVS Health (CVS) stock fell 3.15% recently amid a broader market downturn driven by investor concerns over President Trump's economic policies and his criticisms of Federal Reserve chair Jerome Powell, contributing to overall market volatility. CVS Health (CVS) stock fell by 3.15% following a significant reduction in holdings by CreativeOne Wealth LLC and other hedge funds selling shares, alongside insider selling by a senior vice president, indicating potential investor concerns and profit-taking activities. CVS Health (CVS) stock fell by 3.15%, likely due to a broader negative sentiment in the market reflecting concerns about economic contractions, as indicated by recent investor surveys and the declining U.S. dollar.
	2025-04-17	-1.84 %	CVS Health (CVS) stock decreased by 1.84% due to a sector-wide selloff triggered by UnitedHealth Group's unexpected quarterly earnings miss and lowered profit outlook, which raised concerns about rising medical costs and influenced investor sentiment across the health insurance industry.
CVS Health (CVS) stock decreased by 1.84% due to a sector-wide selloff triggered by UnitedHealth Group's unexpected quarterly earnings miss and lowered profit outlook, which raised concerns about rising medical costs and influenced investor sentiment across the health insurance industry. CVS Health's stock fell nearly 8% following UnitedHealth Group's disappointing earnings report and reduced guidance for 2025, which caused widespread declines in the insurance sector due to concerns over rising medical costs, particularly in Medicare. CVS Health (CVS) stock declined by 1.84% after the company missed first-quarter earnings expectations and reduced its full-year guidance due to unexpectedly high Medicare costs. CVS Health (CVS) stock recently declined by 1.84% amid broader challenges faced by major players in the Medicare Advantage market, particularly due to increased usage among seniors and lower government reimbursements, as highlighted by UnitedHealth's disappointing earnings and revised guidance, which raised concerns over the industry’s profitability. CVS Health (CVS) stock fell by 2% amidst a broader decline in the health insurance sector, particularly after UnitedHealth Group's significant profit forecast cut due to escalating medical costs in Medicare Advantage plans, raising concerns for other insurers like CVS. The decline in CVS's stock is attributed to negative market sentiment following UnitedHealth's announcement of increased medical costs and a bleak outlook, which analysts suggest may foreshadow a challenging environment for other health insurance companies.
	2025-04-15	-0.4 %	CVS Health (CVS) stock fell by 0.4% following disappointing earnings results and higher-than-expected costs in its health insurance arm, Aetna, which have contributed to investor concerns despite the company's recent turnaround efforts.
CVS Health (CVS) stock fell by 0.4% following disappointing earnings results and higher-than-expected costs in its health insurance arm, Aetna, which have contributed to investor concerns despite the company's recent turnaround efforts.